IBD Risk Low in Patients Taking Secukinumab - MedPage Today
IBD Risk Low in Patients Taking Secukinumab MedPage Today
IBD events rare across 21 clinical trials for patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis given the agent.
Comments
Post a Comment